TASLY(SH:600535) Shang Hai Zheng Quan Bao·2025-09-15 18:38Core Viewpoint - The company has announced a guarantee for its wholly-owned subsidiary, aimed at enhancing financing efficiency and reducing costs, with a total guarantee amount not exceeding RMB 900 million for the year 2025 [2][5]. Group 1: Guarantee Details - The company signed a maximum guarantee contract with Minsheng Bank Tianjin Branch on September 15, 2025, providing a joint liability guarantee of RMB 400 million for its pharmaceutical business [2]. - The company has approved a total guarantee amount of up to RMB 900 million for its wholly-owned subsidiaries, including Jiangsu Hongtai Pharmaceutical Co., Ltd. [2][5]. - As of the announcement date, the total balance of guarantees provided by the company to its subsidiaries is RMB 957 million, accounting for 8.04% of the company's latest audited net assets [5]. Group 2: Subsidiary Information - The guaranteed subsidiary has a good credit status and is not listed as a dishonest executor, indicating a stable financial condition [3]. - The company is able to monitor the daily operations, credit status, cash flow, and financial changes of the guaranteed subsidiary, which helps in managing risks effectively [5]. Group 3: Necessity and Reasonableness of the Guarantee - The guarantee aligns with the company's operational needs and overall development strategy, contributing to improved financing efficiency and reduced costs [5]. - The board of directors believes that the overall risk associated with the guarantee is controllable and does not harm the interests of the company and its shareholders [5].